Revolution in the diagnosis of prostate cancer – LiberoQuotidiano.it

Arrives for the first time in Lombardy, Istituto Clinico Beato Matteo, a new technology that has revolutionized the way of biopsy prostatic and greatly improved the reliability of its results. A step forward that experts do not hesitate to define ‘revolutionary’, because until now to perform a biopsy urologist could count on an image ultrasound ultrasound, which is not able to visually show the distinction between healthy tissue and the eventual tumor tissue: to have a sufficiently reliable result the doctor subsequently undertook a sort of ‘map’ of the prostate by taking a large number of tissue samples. In this traditional method, therefore, there was the possibility of verifying the actual spatial location of the drawings: there ie a system to be sure on the one hand not to biopsy several times the same point or the other not to get to draw whole areas of the prostate. To this problem is finally addressing the adoption of three-dimensional ultrasound and with the use of special software that simulate, reconstruct and record the path of the needle within the prostate, “the technology we have to Blessed Matthew and which we have made the first biopsies allows us to finally have a quality control of sampling and reasonably certain to have made a valid mapping of the prostate. The image of the prostate is in three dimensions: the software reconstructs the passage of the needle, the records and also allows us to simulate the taking, so that you can improve and possibly change direction in case of error, “explained Dr. Paul Puppo , responsible Urology Oncology and Minimally Invasive Clinical Institute Beato Matteo.

Another new technology. In addition to the three-dimensional ultrasound has been introduced another technology to transfer information to the ultrasound and magnetic resonance imaging is performed biopsy. A particular software ‘blends’ data of high sensitivity of the resonance three-dimensional ultrasound image, making it possible for the urologist not only a clear mapping of the prostate, but also the vision of differentiated tumor tissue from healthy tissue. The so-called ‘fusion biopsy’ or biopsy with the merger making it possible to ‘take aim’ and concentrate biopsy on suspect areas, significantly increasing the diagnostic accuracy and avoiding unnecessary tests. In this regard, is entering the new function to the Blessed Matthew MRI with endorectal coil suitable for the study of the prostate. Prostate cancer is the most common malignancy in humans. Rare in people under 40 years, its incidence increases progressively with age: it is estimated that the lifetime risk of developing prostate cancer clinically evident is equal to about 15%. Prostate cancer is the most common malignancy in humans. Rare in people under 40 years, its incidence increases progressively with age: it is estimated that the lifetime risk of developing prostate cancer clinically evident is equal to about 15%. ( LARA LUCIANO )